BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

678 related articles for article (PubMed ID: 31087001)

  • 1. Multiplex genome editing of microorganisms using CRISPR-Cas.
    Adiego-Pérez B; Randazzo P; Daran JM; Verwaal R; Roubos JA; Daran-Lapujade P; van der Oost J
    FEMS Microbiol Lett; 2019 Apr; 366(8):. PubMed ID: 31087001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of different types of CRISPR/Cas-based systems in bacteria.
    Liu Z; Dong H; Cui Y; Cong L; Zhang D
    Microb Cell Fact; 2020 Sep; 19(1):172. PubMed ID: 32883277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas9-based genome editing of the filamentous fungi: the state of the art.
    Shi TQ; Liu GN; Ji RY; Shi K; Song P; Ren LJ; Huang H; Ji XJ
    Appl Microbiol Biotechnol; 2017 Oct; 101(20):7435-7443. PubMed ID: 28887634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges of in vitro genome editing with CRISPR/Cas9 and possible solutions: A review.
    Ebrahimi V; Hashemi A
    Gene; 2020 Aug; 753():144813. PubMed ID: 32470504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-Enabled Tools for Engineering Microbial Genomes and Phenotypes.
    Tarasava K; Oh EJ; Eckert CA; Gill RT
    Biotechnol J; 2018 Sep; 13(9):e1700586. PubMed ID: 29917318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-Cas9/CRISPRi tools for cell factory construction in E. coli.
    Hashemi A
    World J Microbiol Biotechnol; 2020 Jun; 36(7):96. PubMed ID: 32583135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploiting endogenous CRISPR-Cas system for multiplex genome editing in Clostridium tyrobutyricum and engineer the strain for high-level butanol production.
    Zhang J; Zong W; Hong W; Zhang ZT; Wang Y
    Metab Eng; 2018 May; 47():49-59. PubMed ID: 29530750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harnessing the type I CRISPR-Cas systems for genome editing in prokaryotes.
    Xu Z; Li Y; Li M; Xiang H; Yan A
    Environ Microbiol; 2021 Feb; 23(2):542-558. PubMed ID: 32510745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of Genome Editing and Transcriptional Control Capabilities Reveals Hierarchies among Diverse CRISPR/Cas Systems in Human Cells.
    Escobar M; Li J; Patel A; Liu S; Xu Q; Hilton IB
    ACS Synth Biol; 2022 Oct; 11(10):3239-3250. PubMed ID: 36162812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR technologies for bacterial systems: Current achievements and future directions.
    Choi KR; Lee SY
    Biotechnol Adv; 2016 Nov; 34(7):1180-1209. PubMed ID: 27566508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances of Cas12a applications in bacteria.
    Meliawati M; Schilling C; Schmid J
    Appl Microbiol Biotechnol; 2021 Apr; 105(8):2981-2990. PubMed ID: 33754170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Future of Multiplexed Eukaryotic Genome Engineering.
    Thompson DB; Aboulhouda S; Hysolli E; Smith CJ; Wang S; Castanon O; Church GM
    ACS Chem Biol; 2018 Feb; 13(2):313-325. PubMed ID: 29241002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application and optimization of CRISPR/Cas system in bacteria].
    Fu J; Yang F; Xie H; Gu F
    Sheng Wu Gong Cheng Xue Bao; 2019 Mar; 35(3):341-350. PubMed ID: 30912343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiplex CRISPR-Cas Genome Editing: Next-Generation Microbial Strain Engineering.
    Lim SR; Lee SJ
    J Agric Food Chem; 2024 May; 72(21):11871-11884. PubMed ID: 38744727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the potential of genome editing CRISPR-Cas9 technology.
    Singh V; Braddick D; Dhar PK
    Gene; 2017 Jan; 599():1-18. PubMed ID: 27836667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of CRISPR/Cas System to Bacterial Metabolic Engineering.
    Cho S; Shin J; Cho BK
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29621180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in CRISPR technologies for genome editing.
    Song M; Koo T
    Arch Pharm Res; 2021 Jun; 44(6):537-552. PubMed ID: 34164771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repurposing CRISPR-Cas Systems as Genetic Tools for the Enterobacteriales.
    Backes N; Phillips GJ
    EcoSal Plus; 2021 Dec; 9(2):eESP00062020. PubMed ID: 34125584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next Generation Prokaryotic Engineering: The CRISPR-Cas Toolkit.
    Mougiakos I; Bosma EF; de Vos WM; van Kranenburg R; van der Oost J
    Trends Biotechnol; 2016 Jul; 34(7):575-587. PubMed ID: 26944793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR Genome Editing Systems in the Genus
    McAllister KN; Sorg JA
    J Bacteriol; 2019 Aug; 201(16):. PubMed ID: 31085694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.